GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,293 | 22 | 191 | 4,268 | 3,674 |
| Receivables | N/A | N/A | 145 | 732 | 865 |
| Inventories | N/A | 3 | 258 | 561 | 650 |
| Income taxes - deferred | N/A | N/A | N/A | 10 | 14 |
| Other current assets | 0 | 250 | 1,914 | 0 | 0 |
| TOTAL | $1,293 | $275 | $2,627 | $5,701 | $5,441 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 45 | 244 | 243 |
| Intangibles | 91 | 315 | 549 | 2,052 | 2,122 |
| Other Non-Current Assets | 0 | 0 | 1,636 | 0 | 0 |
| TOTAL | $91 | $315 | $2,230 | $2,296 | $2,365 |
| Total Assets | $1,384 | $590 | $4,857 | $7,997 | $7,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,945 | 2,123 | 797 | N/A | N/A |
| Accounts payable and accrued liabilities | 925 | 919 | 667 | 763 | 699 |
| Accrued Expenses | 1,404 | 1,029 | 993 | 1,516 | 468 |
| Other current liabilities | 2,405 | 174 | 1,612 | 2,314 | N/A |
| TOTAL | $6,859 | $4,270 | $4,069 | $7,653 | $4,227 |
| Non-Current Liabilities | |||||
| Long Term Debt | 249 | N/A | N/A | 124 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 25 | 0 | 0 |
| TOTAL | $249 | $N/A | $25 | $149 | $41 |
| Total Liabilities | $7,108 | $4,270 | $4,094 | $7,802 | $4,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,403 | 46,851 | 46,851 | 44,527 | 42,538 |
| Common Shares | 67 | 47 | 47 | 45 | 43 |
| Retained earnings | -77,100 | -74,854 | -69,848 | -70,319 | -65,379 |
| Other shareholders' equity | 1 | 1 | -416 | 354 | 188 |
| TOTAL | $-5,724 | $-3,680 | $763 | $195 | $3,538 |
| Total Liabilities And Equity | $1,384 | $590 | $4,857 | $7,997 | $7,806 |